Selected article for: "current outbreak and Germany population spread study"
Author: Barbarossa, Maria Vittoria; Fuhrmann, Jan; Heidecke, Julian; Vinod Varma, Hridya; Castelletti, Noemi; Meinke, Jan H; Krieg, Stefan; Lippert, Thomas
Title: A first study on the impact of current and future control measures on the spread of COVID-19 in Germany
  • Cord-id: 0xymzkzn
  • Document date: 2020_4_11
    • ID: 0xymzkzn
    Snippet: The novel coronavirus (SARS-CoV-2), identified in China at the end of December 2019 and causing the disease COVID-19, has meanwhile led to outbreaks all over the globe, with about 571,700 confirmed cases and about 26,500 deaths as of March 28th, 2020. We present here the preliminary results of a mathematical study directed at informing on the possible application or lifting of control measures in Germany. The developed mathematical models allow to study the spread of COVID-19 among the populatio
    Document: The novel coronavirus (SARS-CoV-2), identified in China at the end of December 2019 and causing the disease COVID-19, has meanwhile led to outbreaks all over the globe, with about 571,700 confirmed cases and about 26,500 deaths as of March 28th, 2020. We present here the preliminary results of a mathematical study directed at informing on the possible application or lifting of control measures in Germany. The developed mathematical models allow to study the spread of COVID-19 among the population in Germany and to asses the impact of non-pharmaceutical interventions. The overall goal is to suggest strategies for the mitigation of the current outbreak, slowing down the spread of the virus and thus reducing the peak in daily diagnosed cases, the demand for hospitalization or intensive care units admissions, and eventually fatalities.

    Search related documents:
    Co phrase search for related documents
    • abrupt start and additional testing: 1
    • account age and active case: 1
    • account age and active control: 1
    • account age and long period: 1
    • active case and additional benefit: 1
    • active case and additional measure: 1
    • active case and additional testing: 1, 2, 3, 4
    • active control and additional benefit: 1
    • active control and additional testing: 1
    • active control and long period: 1, 2
    • active infection and additional testing: 1, 2
    • active infection and long period: 1
    • active infection and low contact rate: 1, 2, 3